Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retraction notice to "A feasibility study of the combination of intranasal insulin with dulaglutide for cognition in older adults with metabolic syndrome at high dementia risk- Study rationale and design" [Mech. Ageing Dev. 213 (2023) 111825].
Davidy T, Yore I, Cukierman-Yaffe T, Ravona-Springer R, Livny A, Lesman-Segev OH, Azuri Y, Carmichael O, Kapogiannis D, Zetterberg H, Lin H, Sano M, Beeri MS. Davidy T, et al. Mech Ageing Dev. 2024 May 3:111937. doi: 10.1016/j.mad.2024.111937. Online ahead of print. Mech Ageing Dev. 2024. PMID: 38702256 No abstract available.
A feasibility study of the combination of intranasal insulin with oral semaglutide for cognition in older adults with metabolic syndrome at high dementia risk- Study rationale and design.
Davidy T, Yore I, Cukierman-Yaffe T, Ravona-Springer R, Livny A, Lesman-Segev OH, Azuri Y, Carmichael O, Kapogiannis D, Zetterberg H, Lin H, Sano M, Beeri MS. Davidy T, et al. Mech Ageing Dev. 2024 Apr;218:111898. doi: 10.1016/j.mad.2023.111898. Epub 2023 Dec 29. Mech Ageing Dev. 2024. PMID: 38159613 Clinical Trial.
A feasibility study of the combination of intranasal insulin with dulaglutide for cognition in older adults with metabolic syndrome at high dementia risk - Study rationale and design.
Davidy T, Yore I, Cukierman-Yaffe T, Ravona-Springer R, Livny A, Lesman-Segev OH, Azuri Y, Carmichael O, Kapogiannis D, Zetterberg H, Lin H, Sano M, Beeri MS. Davidy T, et al. Mech Ageing Dev. 2023 Jul;213:111825. doi: 10.1016/j.mad.2023.111825. Epub 2023 May 26. Mech Ageing Dev. 2023. PMID: 37245533 Retracted. Clinical Trial.
Amelanotic conjunctival melanoma in a child.
Vishnevskia-Dai V, Davidy T, Zloto O. Vishnevskia-Dai V, et al. Among authors: davidy t. Am J Ophthalmol Case Rep. 2022 Nov 11;29:101735. doi: 10.1016/j.ajoc.2022.101735. eCollection 2023 Mar. Am J Ophthalmol Case Rep. 2022. PMID: 36582844 Free PMC article.